HD11 for Intermediate Stages
This study is designed to (1) compare the efficacy of the BEACOPP regimen with that of ABVD as a 4-cycle chemotherapy combined with an involved field irradiation and (2) to define the optimum radiation dose comparing of 30 to 20 Gy in the same context.
HodgkinÂ´s Lymphoma
DRUG: Adriamycin|DRUG: Bleomycin|DRUG: Vinblastine|DRUG: DTIC|DRUG: Etoposide|DRUG: Procarbazine|DRUG: Prednisone|DRUG: Vincristine|RADIATION: radiation therapy
This study is designed to (1) compare the efficacy of the BEACOPP regimen with that of ABVD as a 4-cycle chemotherapy combined with an involved field irradiation and (2) to define the optimum radiation dose comparing of 30 to 20 Gy in the same context.